Current overview of the role of Akt in cancer studies via applied immunohistochemistry

Annals of Diagnostic Pathology

Volumn 12, Issue 2, 2008, Pages 153-160

  Shtilbans, Viktor ^a   Wu, Maoxin ^b   Burstein, David E ^c  

^a Genzyme Genetics   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

AKT; Cancer; Immunohistochemistry

Indexed keywords

AKT 1 PROTEIN; AKT 3 PROTEIN; HORMONE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROSTATE SPECIFIC ANTIGEN; PROTEIN KINASE B; PROTEIN KINASE B BETA; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

BARRETT ESOPHAGUS; BREAST ADENOCARCINOMA; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER SURVIVAL; CANCER THERAPY; CARCINOGENESIS; CARCINOMA IN SITU; CENTRAL NERVOUS SYSTEM TUMOR; COLON ADENOCARCINOMA; DIFFERENTIAL DIAGNOSIS; ENDOMETRIUM CARCINOMA; ESOPHAGEAL ADENOCARCINOMA; HEAD AND NECK CARCINOMA; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MENINGIOMA; MOUTH CARCINOMA; MULTIPLE MYELOMA; NEOPLASM; NONHODGKIN LYMPHOMA; OVARY ADENOCARCINOMA; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOSENSITIVITY; REVIEW; SOFT TISSUE SARCOMA; SQUAMOUS CELL CARCINOMA; STOMACH CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; UTERINE CERVIX CARCINOMA; UVEA MELANOMA;

EID: 39749127809     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2007.12.001     Document Type: Review

References (79)

1. D.P. Brazil B.A. Hemmings Ten years of protein kinase B signalling: a hard Akt to follow Trends Biochem Sci 26 11 2001 657 664
2. M. Osaki M. Oshimura H. Ito PI3K-Akt pathway: its functions and alterations in human cancer Apoptosis 9 6 2004 667 676
3. A. Bellacosa T.F. Franke M.E. Gonzalez-Portal K. Datta T. Taguchi J. Gardner Structure, expression and chromosomal mapping of c-akt: relationship to v-akt and its implications Oncogene 8 3 1993 745 754
4. M. Sun G. Wang J.E. Paciga R.I. Feldman Z.Q. Yuan X.L. Ma AKT1/PKB alpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells Am J Pathol 159 2 2001 431 437
5. I.G. Maroulakou W. Oemler S.P. Naber P.N. Tsichlis Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice Cancer Res 67 1 2007 167 177
6. S.S. Bae H. Cho J. Mu M.J. Birnbaum Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B J Biol Chem 278 49 2003 49530 49536
7. R.S. Garofalo S.J. Orena K. Rafidi A.J. Torchia J.L. Stock A.L. Hildebrandt Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta J Clin Invest 112 2 2003 197 208
8. E.M. Sale C.P. Hodgkinson N.P. Jones G.J. Sale A new strategy for studying protein kinase B and its three isoforms. Role of protein kinase B in phosphorylating glycogen synthase kinase-3, tuberin, WNK1, and ATP citrate lyase Biochemistry 45 1 2006 213 223
9. M.E. Cleasby T.A. Reinten G.J. Cooney D.E. James E.W. Kraegen Functional studies of Akt isoform specificity in skeletal muscle in vivo; maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression Mol Endocrinol 21 1 2007 215 228
10. R.M. Easton H. Cho K. Roovers D.W. Shineman M. Mizrahi M.S. Forman Role for Akt3/protein kinase Bgamma in attainment of normal brain size Mol Cell Biol 25 5 2005 1869 1878
11. Z.Z. Yang O. Tschopp A. Baudry B. Dummler D. Hynx B.A. Hemmings Physiological functions of protein kinase B/Akt Biochem Soc Trans 32 Pt 2 2004 350 354
12. P.K. Vogt M. Aoki I. Bottoli H.W. Chang S. Fu A. Hecht A random walk in oncogene space: the quest for targets Cell Growth Differ 10 12 1999 777 784
13. S. Masure B. Haefner J.J. Wesselink E. Hoefnagel E. Mortier P. Verhasselt Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3 Eur J Biochem 265 1 1999 353 360
14. K.M. Nicholson N.G. Anderson The protein kinase B/Akt signalling pathway in human malignancy Cell Signal 14 5 2002 381 395
15. M. Hanada J. Feng B.A. Hemmings Structure, regulation and function of PKB/AKT—a major therapeutic target Biochim Biophys Acta 1697 1-2 2004 3 16
16. G. Song G. Ouyang S. Bao The activation of Akt/PKB signaling pathway and cell survival J Cell Mol Med 9 1 2005 59 71
17. S. Chan Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer Br J Cancer 91 8 2004 1420 1424
18. S.M. Janes F.M. Watt Switch from alphavbeta5 to alphavbeta6 integrin expression protects squamous cell carcinomas from anoikis J Cell Biol 166 3 2004 419 431
19. Zhan M Zhao H Han ZC Signalling mechanisms of anoikis Histol Histopathol 19 3 2004 973 983
20. A. Suzuki G. Kusakai A. Kishimoto J. Lu T. Ogura M.F. Lavin Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein J Biol Chem 278 1 2003 48 53
21. G. Kusakai A. Suzuki T. Ogura M. Kaminishi H. Esumi Strong association of ARK5 with tumor invasion and metastasis J Exp Clin Cancer Res 23 2 2004 263 268
22. M.G. Slomiany L.A. Black M.M. Kibbey T.A. Day S.A. Rosenzweig IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma Biochem Biophys Res Commun 342 3 2006 851 858
23. S. Dimmeler A.M. Zeiher Akt takes center stage in angiogenesis signaling Circ Res 86 1 2000 4 5
24. J. Downward PI 3-kinase, Akt and cell survival Semin Cell Dev Biol 15 2 2004 177 182
25. A. Bellacosa C.C. Kumar A. Di Cristofano J.R. Testa Activation of AKT kinases in cancer: implications for therapeutic targeting Adv Cancer Res 94 2005 29 86
26. S.J. Grille A. Bellacosa J. Upson A.J. Klein-Szanto F. van Roy W. Lee-Kwon The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines Cancer Res 63 9 2003 2172 2178
27. L. Larue A. Bellacosa Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways Oncogene 24 50 2005 7443 7454
28. T. Onoue D. Uchida N.M. Begum Y. Tomizuka H. Yoshida M. Sato Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells Int J Oncol 29 5 2006 1133 1138
29. D. Kim S. Kim H. Koh S.O. Yoon A.S. Chung K.S. Cho Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production Faseb J 15 11 2001 1953 1962
30. K.H. Chun J.W. Kosmeder II S. Sun J.M. Pezzuto R. Lotan W.K. Hong Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells J Natl Cancer Inst 95 4 2003 291 302
31. A.F. Baker T. Dragovich N.T. Ihle R. Williams C. Fenoglio-Preiser G. Powis Stability of phosphoprotein as a biological marker of tumor signaling Clin Cancer Res 11 12 2005 4338 4340
32. S.N. Malik M. Brattain P.M. Ghosh D.A. Troyer T. Prihoda R. Bedolla Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer Clin Cancer Res 8 4 2002 1168 1171
33. P. Amornphimoltham V. Sriuranpong V. Patel F. Benavides C.J. Conti J. Sauk Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01 Clin Cancer Res 10 12 Pt 1 2004 4029 4037
34. J.W. Tichelaar Y. Zhang J.C. leRiche P.W. Biddinger S. Lam M.W. Anderson Increased staining for phospho-Akt, p65/RELA and cIAP-2 in pre-neoplastic human bronchial biopsies BMC Cancer 5 2005 155
35. T. Kirkegaard C.J. Witton L.M. McGlynn S.M. Tovey B. Dunne A. Lyon AKT activation predicts outcome in breast cancer patients treated with tamoxifen J Pathol 207 2 2005 139 146
36. A.K. Gupta W.G. McKenna C.N. Weber M.D. Feldman J.D. Goldsmith R. Mick Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction Clin Cancer Res 8 3 2002 885 892
37. W.M. Ongkeko X. Altuna R.A. Weisman J. Wang-Rodriguez Expression of protein tyrosine kinases in head and neck squamous cell carcinomas Am J Clin Pathol 124 1 2005 71 76
38. J. Lim J.H. Kim J.Y. Paeng M.J. Kim S.D. Hong J.I. Lee Prognostic value of activated Akt expression in oral squamous cell carcinoma J Clin Pathol 58 11 2005 1199 1205
39. E. Massarelli D.D. Liu J.J. Lee A.K. El-Naggar L. Lo Muzio S. Staibano Akt activation correlates with adverse outcome in tongue cancer Cancer 104 11 2005 2430 2436
40. Z. Yu P.M. Weinberger C. Sasaki B.L. Egleston W.F.T. Speier B. Haffty Phosphorylation of Akt (Ser473) predicts poor clinical outcome in oropharyngeal squamous cell cancer Cancer Epidemiol Biomarkers Prev 16 3 2007 553 558
41. T.J. Kim J.W. Lee S.Y. Song J.J. Choi C.H. Choi B.G. Kim Increased expression of pAKT is associated with radiation resistance in cervical cancer Br J Cancer 94 11 2006 1678 1682
42. Y. Kanamori J. Kigawa H. Itamochi M. Shimada M. Takahashi S. Kamazawa Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma Clin Cancer Res 7 4 2001 892 895
43. N. Terakawa Y. Kanamori S. Yoshida Loss of PTEN expression followed by Akt phosphorylation is a poor prognostic factor for patients with endometrial cancer Endocr Relat Cancer 10 2 2003 203 208
44. K. Uegaki Y. Kanamori J. Kigawa W. Kawaguchi R. Kaneko J. Naniwa PTEN-positive and phosphorylated–Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma Oncol Rep 14 2 2005 389 392
45. T. Minaguchi S. Nakagawa Y. Takazawa T. Nei K. Horie T. Fujiwara Combined phospho-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium Cancer Lett 248 1 2007 112 122
46. Z.Q. Yuan M. Sun R.I. Feldman G. Wang X. Ma C. Jiang Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer Oncogene 19 19 2000 2324 2330
47. D.A. Altomare H.Q. Wang K.L. Skele A. De Rienzo A.J. Klein-Szanto A.K. Godwin AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth Oncogene 23 34 2004 5853 5857
48. B.E. Cristiano J.C. Chan K.M. Hannan N.A. Lundie N.J. Marmy-Conus I.G. Campbell A specific role for AKT3 in the genesis of ovarian cancer through modulation of G(2)-M phase transition Cancer Res 66 24 2006 11718 11725
49. J. Woenckhaus K. Steger K. Sturm K. Munstedt F.E. Franke I. Fenic Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer Virchows Arch 450 4 2007 387 395
50. G. Perez-Tenorio O. Stal Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients Br J Cancer 86 4 2002 540 545
51. X. Zhou M. Tan V. Stone Hawthorne K.S. Klos K.H. Lan Y. Yang Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers Clin Cancer Res 10 20 2004 6779 6788
52. S.B. Vestey C. Sen C.J. Calder C.M. Perks M. Pignatelli Z.E. Winters Activated Akt expression in breast cancer: correlation with p53, Hdm2 and patient outcome Eur J Cancer 41 7 2005 1017 1025
53. E. Tokunaga A. Kataoka Y. Kimura E. Oki K. Mashino K. Nishida The association between Akt activation and resistance to hormone therapy in metastatic breast cancer Eur J Cancer 42 5 2006 629 635
54. E. Tokunaga Y. Kimura K. Mashino E. Oki A. Kataoka S. Ohno Activation of PI3K/Akt signaling and hormone resistance in breast cancer Breast Cancer 13 2 2006 137 144
55. Y. Liao R. Grobholz U. Abel L. Trojan M.S. Michel P. Angel Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer Int J Cancer 107 4 2003 676 680
56. J.I. Kreisberg S.N. Malik T.J. Prihoda R.G. Bedolla D.A. Troyer S. Kreisberg Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer Cancer Res 64 15 2004 5232 5236
57. G. Ayala T. Thompson G. Yang A. Frolov R. Li P. Scardino High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence Clin Cancer Res 10 19 2004 6572 6578
58. C. Le Page I.H. Koumakpayi M. Alam-Fahmy A.M. Mes-Masson F. Saad Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients Br J Cancer 94 12 2006 1906 1912
59. A. Horiguchi M. Oya A. Uchida K. Marumo M. Murai Elevated Akt activation and its impact on clinicopathological features of renal cell carcinoma J Urol 169 2 2003 710 713
60. H.K. Roy B.F. Olusola D.L. Clemens W.J. Karolski A. Ratashak H.T. Lynch AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis Carcinogenesis 23 1 2002 201 205
61. S.Y. Nam H.S. Lee G.A. Jung J. Choi S.J. Cho M.K. Kim Akt/PKB activation in gastric carcinomas correlates with clinicopathologic variables and prognosis Apmis 111 12 2003 1105 1113
62. S. Yamamoto Y. Tomita Y. Hoshida T. Morooka H. Nagano K. Dono Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma Clin Cancer Res 10 8 2004 2846 2850
63. D.A. Altomare S. Tanno A. De Rienzo A.J. Klein-Szanto S. Tanno K.L. Skele Frequent activation of AKT2 kinase in human pancreatic carcinomas J Cell Biochem 87 2002 470 476
64. I.L. Beales O. Ogunwobi E. Cameron K. El-Amin G. Mutungi M. Wilkinson Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study BMC Cancer 7 2007 97
65. O. David J. Jett H. LeBeau G. Dy J. Hughes M. Friedman Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage Clin Cancer Res 10 20 2004 6865 6871
66. P.P. Massion P.M. Taflan Y. Shyr S.M. Rahman P. Yildiz B. Shakthour Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression Am J Respir Crit Care Med 170 10 2004 1088 1094
67. Y.D. Liao Q.H. Long S. Zhou J.P. Zhao Q. Huang X.N. Fu [Expression of PKB protein in human squamous-cell carcinoma and adenocarcinoma of lung] Zhonghua Zhong Liu Za Zhi 27 3 2005 156 159
68. A. Shah W.A. Swain D. Richardson J. Edwards D.J. Stewart C.M. Richardson Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer Clin Cancer Res 11 8 2005 2930 2936
69. W.T. Lim W.H. Zhang C.R. Miller J.W. Watters F. Gao A. Viswanathan PTEN and phosphorylated AKT expression and prognosis in early-and late-stage non-small cell lung cancer Oncol Rep 17 4 2007 853 857
70. T. Dutu S. Michiels P. Fouret F. Penault-Llorca P. Validire S. Benhamou Differential expression of biomarkers in lung adenocarcinoma: a comparative study between smokers and never-smokers Ann Oncol 16 12 2005 1906 1914
71. V. Vasko M. Saji E. Hardy M. Kruhlak A. Larin V. Savchenko Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer J Med Genet 41 3 2004 161 170
72. C. Mawrin T. Sasse E. Kirches S. Kropf T. Schneider C. Grimm Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas Clin Cancer Res 11 11 2005 4074 4082
73. D.A. Haas-Kogan M.D. Prados T. Tihan D.A. Eberhard N. Jelluma N.D. Arvold Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib J Natl Cancer Inst 97 12 2005 880 887
74. V.S. Saraiva A.L. Caissie L. Segal C. Edelstein M.N. Burnier Jr Immunohistochemical expression of phospho-Akt in uveal melanoma Melanoma Res 15 4 2005 245 250
75. A. Slipicevic R. Holm M.T. Nguyen P.J. Bohler B. Davidson V.A. Florenes Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcome Am J Clin Pathol 124 4 2005 528 536
76. Y. Tomita T. Morooka Y. Hoshida B. Zhang Y. Qiu I. Nakamichi Prognostic significance of activated AKT expression in soft-tissue sarcoma Clin Cancer Res 12 10 2006 3070 3077
77. J. Hsu Y. Shi S. Krajewski S. Renner M. Fisher J.C. Reed The AKT kinase is activated in multiple myeloma tumor cells Blood 98 9 2001 2853 2855
78. S. Alkan K.F. Izban Immunohistochemical localization of phosphorylated AKT in multiple myeloma Blood 99 6 2002 2278 2279
79. G.C. Fillmore Q. Wang M.J. Carey C.H. Kim K.S. Elenitoba-Johnson M.S. Lim Expression of Akt (protein kinase B) and its isoforms in malignant lymphomas Leuk Lymphoma 46 12 2005 1765 1773